Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
| Status: | Terminated |
|---|---|
| Conditions: | Liver Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/2/2016 |
| Start Date: | May 2010 |
| End Date: | January 2012 |
Impact of C-arm CT in Patients With Decreased Renal Function Undergoing Transhepatic Arterial Chemoembolization (TACE) for the Treatment of Hepato-Cellular Carcinoma
Impact on contrast dose or total volume of contrast required to effectively treat the
targeted tumor.
targeted tumor.
Inclusion Criteria:
1. Patients must be affected by HCC
2. Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
3. Patients must be 18 years old or older
4. Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to
the TACE procedure.
5. Ability to understand and the willingness to sign a written informed consent
document.
Exclusion Criteria:
1. Subjects under the age of 18
2. Patients currently on dialysis
3. Pregnant women
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
